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Abstract
eNOS activation resulting in mitochondrial biogenesis is believed to play a central role in life span extension promoted by
calorie restriction (CR). We investigated the mechanism of this activation by treating vascular cells with serum from CR rats
and found increased Akt and eNOS phosphorylation, in addition to enhanced nitrite release. Inhibiting Akt phosphorylation
or immunoprecipitating adiponectin (found in high quantities in CR serum) completely prevented the increment in nitrite
release and eNOS activation. Overall, we demonstrate that adiponectin in the serum from CR animals increases NON
signaling by activating the insulin pathway. These results suggest this hormone may be a determinant regulator of the
beneficial effects of CR.
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Introduction
Calorie restriction (CR) extends lifespans of model organisms
ranging from yeast to mammals [1–4], and many groups have
focused on understanding how this dietary intervention acts
mechanistically. In 2005, Nisoli and collaborators [5] elegantly
demonstrated that dietary restriction induced the activation of
endothelial nitric oxide synthase (eNOS) and lead to enhanced
mitochondrial biogenesis and increased oxygen consumption.
Indeed, the effects of the diet were largely absent in eNOS
deficient animals [5]. Further studies have found links between
mitochondrial activity and CR. Fungal CR models present
increments in respiratory activity [6–8], and CR in yeast can be
promoted by NON-stimulated mitochondrial biogenesis [9].
Furthermore, CR prevents the decline in respiratory activity seen
in aging rats [10,11] and increasing respiratory activity through
the use of mitochondrial uncouplers enhances mouse lifespan [12].
Interestingly, both CR and uncouplers enhance mitochondrial
biogenesis in insulin-sensitive tissues, in a manner involving
protein kinase B (Akt) phosphorylation [13].
Insulin is involved in the control of eNOS phosphorylation and
activity [14–18]. It activates Akt [17,19,20], which promotes
eNOS activation [21], increasing the production of nitric oxide
(NON) and leading to mitochondrial biogenesis [22–25] through
the expression of the peroxisome proliferator-activated receptor-c
coactivator 1a (PGC-1a), a master regulator of mitochondrial
mass (reviewed in [26,27]).
The mechanism which leads to NON signaling and mitochon-
drial biogenesis in response to CR was not well explored to date.
Mammals submitted to CR present lower insulin levels [13,28,29],
but improved tissue insulin sensitivity [13,30], in part due to long-
term decreases in blood glucose [31]. We investigate here if
changes in serological profiles in CR animals are sufficient to
acutely promote NON signaling in cultured vascular cells, and
uncover the signaling pathways involved.
Results
CR decreases serum glucose and insulin; increases
adiponectin levels
After 26 weeks of CR, the average body weight of rats was lower
than control AL rats, an effect accompanied by lower visceral fat
deposits, serum glucose, insulin, and increased adiponectin levels
(Table 1), alterations similar to those observed in most literature
CR studies [28].
CR serum increases NON production
VSMC cells incubated in media in which standard serum was
substituted for serum collected from CR rats presented a time-
dependent increase in NO2
2, indicative of higher levels of NON
production compared to cells maintained in media containing
serum from animals fed AL (Fig. 1A). This result shows that acute
treatment with serum from CR animals is sufficient to increase
VSMC NON production, and suggests CR serum contains
regulatory signals leading to this effect.
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We sought to determine the source of this augmented NON
production by measuring the activities of eNOS in cells which
had been cultured in AL media and were then switched to media
containing serum from CR animals. Under these conditions, the
quantity of total eNOS increased significantly after 24 h (by
20368%, p,0.05). Furthermore, active, phosphorylated, eNOS
increased (Fig. 1B shows a representative blot of the time-
dependent effect of incubation in CR serum, while Fig. 1C
quantifies relative phosphorylated band intensity after 24 h in
AL or CR sera). Overall, these results indicate that eNOS
expression and activation is promoted by serological changes
induced by CR.
CR serum increases insulin signaling
We have previously shown that Akt and eNOS are activated in
insulin-sensitive tissues of CR animals [13]. We sought to measure
the activity of this pathway in VSMC cells cultured in the presence
of CR serum (Fig. 2) and found that the active, phosphorylated,
form of Akt increased in a time-dependent manner in CR media,
from undetectable levels in AL serum (Fig. 2A, upper panels).
Indeed, after 24 h in CR serum, a highly significant change in p-
Akt levels was detected relative to AL serum (Fig. 2B).
Among other pathways controlling Akt, this protein is sensitive
to insulin signaling. Although insulin levels in CR serum are
decreased relative to AL (Table 1), we measured the activation of
insulin receptors (IR) from VSMC grown 24 h in AL and CR
media. The receptors were immunoprecipitated and probed with
anti-phospho-Tyr antibodies. CR serum significantly enhanced
the total amount of IR by 19468%, p,0.05, and lead to a strong
increment in receptor phosphorylation (Figs. 2A and 2B),
indicating that it contains components other than insulin capable
of acutely activating the insulin pathway.
CR serum-induced NON release is dependent on Akt
In order to investigate if enhanced NON release from VSMC
cells was dependent on the activation of the insulin pathway, we
inhibited Akt activity with 1 mM naphthyridinone 17 (NTD). This
concentration of NTD completely prevented the accumulation of
NO2
2 promoted by CR serum, but did not affect the release in
cells grown in AL serum (Fig. 3A). Furthermore, NTD completely
eliminated the detection of phospho-eNOS and decreased total
eNOS band intensity (Fig. 3B). This is consistent with the finding
that Akt activity is important for eNOS phosphorylation [21].
Adiponectin mediates the activation of the insulin
pathway and NON release induced by CR serum
The activation of the insulin pathway in cells acutely treated
with CR serum is surprising since insulin levels are lower (Table 1).
However, adiponectin levels are increased in CR, and this
hormone is an activator of the insulin pathway [32,33]. To
address the role of adiponectin in the CR serum effect on NON
release, we removed it through immunoprecipitation. The
procedure was highly effective (Fig. 4A). Using immunoprecipi-
tated sera, we noted that the phosphorylation of insulin receptors
promoted by CR serum was eliminated (Fig. 4B), while no effect
was seen in AL serum. Immunoprecipitation of adiponectin also
totally reversed the effect of CR serum on eNOS phosphorylation
(Fig. 4C) and on NO2
2 release (Fig. 4D). Overall, these results
indicate that enhanced NON release promoted by CR serum in
vascular cells is a consequence of high adiponectin levels.
Discussion
Mitochondrial mass and function decrease during aging [34–
36] in a manner prevented by CR, which promotes enhanced NON
signaling associated with mitochondrial biogenesis [5,6,11,13].
Thus, NON signaling seems to be central toward the beneficial
effects of CR in aging, although the mechanisms through which
CR affects this pathway have not been directly approached to
date. We addressed this point by treating VSMC, prone to
respond to physiological stimuli that affect NON release [37,38],
with serum collected from CR animals. This protocol has the
advantage of separating long-term dietary effects from acute effects
on vascular cells, specifically addressing the question if hormonal
changes in CR are sufficient to activate NON signaling.
We observed a time-dependent increment in NO2
2 released
into the culture medium, indicative of enhanced NON production,
as well as increments in eNOS quantity and phosphorylation
(Fig. 1), a result in line with previous data showing that CR
Table 1. Effects of CR and AL diets.
CR AL P value
Body weight (g) 481.5682.9 675.7693.1 ,0.0001
Visceral fat (g) 23.969.8 31.267.9 0.0009
Serum glucose (mg?dL21) 85.863.7 115.166.6 0.0008
Serum insulin (ng?mL21) 0.5860.29 1.9860.85 ,0.0001
Serum adiponectin (relative to AL) 3.060.7 1 ,0.0001
Measurements were conducted as described in Materials and Methods.
doi:10.1371/journal.pone.0031155.t001
Figure 1. CR serum increases NO2
2 release and promotes eNOS and nNOS phosphorylation. (A) Culture media NO2
2 was measured over
time after incubation in AL or CR sera, as indicated. (B) eNOS phosphorylation and expression over time after switching from AL to CR serum.
Representative blots are shown. (C). Quantification of eNOS phosphorylation after 24 h in AL or CR sera. *p,0.05 versus AL.
doi:10.1371/journal.pone.0031155.g001
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induced the expression of eNOS through Akt [5,13,17,19,20].
Indeed, Akt phosphorylation was strongly enhanced by CR serum
(Fig. 2) and NTD (a selective Akt inhibitor when used at low
micromolar doses [39]) inhibited eNOS phosphorylation (Fig. 3).
The insulin receptor, an upstream regulator of Akt activity and
eNOS activation [40], was also activated by CR serum (Fig. 2).
Insulin signaling is well known to activate NON signaling, and Akt
physically interacts with eNOS in response to insulin [41].
However, insulin is found at decreased levels in CR serum while
adiponectin, an activator of peripheral insulin signaling [32,33], is
increased (Table 1, [42,43]). Furthermore, adiponectin was
previously reported to activate eNOS through Akt [44,45].
Accordingly, we sought to determine if adiponectin in CR
serum could activate NON signaling. We immunoprecipitated
adiponectin from both AL and CR sera (Fig. 4A), and found that,
while this did not alter the release of NO2
2 promoted by AL
serum, it completely abrogated the increased release specific to CR
serum (Fig. 4D). In addition, increased activation of the insulin
pathway and eNOS were absent upon removal of adiponectin
(Figs. 4B and C). Together, these results demonstrate that
adiponectin is the key regulator of enhanced NON signaling in
vascular cells stimulated with CR serum.
It should be noted that VSMCs present different signaling
receptors and pathways than endothelial cells, which could thus
present different responses to CR sera. However, previous results
demonstrate that adiponectin stimulates NON release from
endothelial cells [46], supporting the idea that this cytokine is
probably a key signaling molecule in CR-induced NON signaling.
Interestingly, it seems that eNOS-derived NON can also have a
determinant role in regulating the production of adiponectin by
adipocytes [47].
Overall, our results point to adiponectin as a key serological
factor involved in acute cellular responses altered by CR, and
suggest that this hormone may be a central regulator of
Figure 3. CR-induced NO2
2 release is dependent on Akt
activity. (A) NO2
2 levels in the culture medium from VSMC incubated
24 h with AL or CR serum and 0.001% DMSO (solvent control) or 1 mM
NTD. (B) eNOSSer1177 phosphorylation in homogenates from VSMC
incubated 24 h with AL or CR serum and 0.001% DMSO or 1 mM NTD.
*p,0.05 versus AL; #p,0.05 versus DMSO. Representative blots are
shown above quantifications.
doi:10.1371/journal.pone.0031155.g003
Figure 4. Adiponectin in CR serum promotes insulin receptor
and eNOS phosphorylation, resulting in NON release. (A)
Adiponectin levels in AL and CR sera before and after immunoprecip-
itation (IP). (B) Tyr phosphorylation in insulin receptors immunoprecip-
itated from homogenates of VSMC cultured for 24 h in the presence of
CR or AL serum, with (IP) or without (Control) prior adiponectin
immunoprecipitation. (C) eNOSSer1177 phosphorylation in homogenates
from VSMC cultured for 24 h in the presence of CR or AL serum, with
(IP) or without (Control) prior adiponectin immunoprecipitation. (D)
NO2
2 levels in the media from VSMC cultured for 24 h in the presence
of CR or AL serum, with (IP) or without (Control) prior adiponectin
immunoprecipitation. *p,0.05 versus AL; #p,0.05 versus control.
Representative blots, shown above quantifications, were cut to remove
other bands, without any further image manipulation.
doi:10.1371/journal.pone.0031155.g004
Figure 2. CR serum activates the insulin pathway. (A) Upper
blots: AktSer473 phosphorylation over time after switching from AL to CR
serum. Lower blots: Tyr phosphorylation in insulin receptors (IR)
immunoprecipitated from VSMC cultured for 24 h in AL or CR media.
Representative blots are shown. (B) Quantification of pAkt/Akt and p-IR/
IR after 24 h in AL or CR sera. *p,0.05 versus AL.
doi:10.1371/journal.pone.0031155.g002
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mitochondrial biogenesis and other processes involving NON
signaling.
Materials and Methods
Animals and serum collection
All experiments were conducted in agreement with National
Institutes of Health guidelines for humane treatment of animals
and were approved (unnumbered) the local Animal Care and Use
Committee (Comissa˜o de E´tica em Cuidados e Uso Animal). Male, 8-
week-old Sprague-Dawley rats were separated into 2 groups: AL,
fed ad libitum with an AIN-93-M diet prepared by Rhoster
(Campinas, SP, Brazil) and CR, fed at levels 60% of AL ingested
amounts a diet supplemented with micronutrients to reach the
vitamin and mineral levels consumed by AL animals [48]. Food
was offered daily at 6 pm and feedings were adjusted weekly by
weight, based on AL food consumption. The intervention resulted
in known alterations associated with CR including lower body
weight and improved insulin sensitivity [49]. The animals were
lodged 3 per cage and given water ad libitum. At 34 weeks (26 weeks
on the diet), rats were sacrificed after 12 hours fasting and the
serum was obtained as described in [50], allowed to clot for 20–
30 min at 25uC and centrifuged for 20 min at 300 g. The
supernatant was collected and stored (220uC). Sera were thawed
and heat-inactivated at 56uC for 30 min prior to use.
Serum analysis
Insulin, glucose, triglycerides, HDL, total cholesterol and
adiponectin levels from AL or CR sera were evaluated (Table 1).
Peripheral blood was collected from the tail of 40-week-old animals
fasted for 12 hours and used for glucose analysis (Accu-CheckH
Performa Glucose Analyzer, Sa˜o Paulo, SP, Brazil). For insulin and
adiponectin determinations, blood samples were centrifuged at
1000 g for 15 min and the supernatant was stored at220uC. Insulin
was measured using a Linco Research ELISA kit (St. Charles, MO,
USA). Adiponectin was detected by Western Blots.
Cell cultures
Rat vascular smooth muscle cells (VSMC) were purchased from
ATCC (CRL-2797TM) and cultured in 25 mM glucose DMEM
supplemented with 18 mM sodium bicarbonate, 4 mM glutamine,
0.3 mM geneticin, 100 mg/mL streptomycin, 100 U/mL penicil-
lin and 10% v/v fetal bovine serum, at 37uC and 5% CO2. Cells
were passaged every 3 days. After the 8th passage, cells were
cultured in medium where fetal bovine serum was substituted for
AL rat serum. After 2 further passages, cells from a 70% confluent
flask were washed and cultured in DMEM with CR or AL rat sera.
Where used, naphthyridinone 17 (NTD) was pre-incubated with
the cultures for 24 hours, while the control group was incubated
with the same quantity of the solvent DMSO.
After 6, 12 or 24 hours, cell culture media were removed and
stored at 280uC for NO2
2 measurements. Cells were washed,
detached and counted in a Newbauer chamber. The cells were
then centrifuged (300 g, 5 min, 4uC) and homogenized in 50 mM
Tris-HCl buffer, pH 7.4, supplemented with 1% glycerol, 10%
protease inhibitor cocktail (Sigma), 1% octyl phenol ethoxylate,
10 mM sodium orthovanadate, 10 mM sodium fluoride and
10 mM sodium pyrophosphate. After 30 min over ice, cell lysates
were centrifuged (13,000 g, 20 min, 4uC) and the resulting
supernatants were collected.
NO2
2 levels
NO2
2, a marker of NON levels [51], was measured using an NON
analyzer (Model 208A; Sievers Instruments Inc., Boulder, CO,
USA) according to manufacturer protocols through the detection
of chemiluminescence in the presence of potassium iodide and
acetic acid [52,53]. Basal NO2
2 levels from the media were
subtracted.
Western Blots
Total proteins from cell lysates or serum were diluted in
Laemmli sample buffer (100 mM Tris.HCl, 2% w/v SDS, 10% v/
v glycerol, 0.1% bromophenol blue) containing 100 mM dithio-
threitol, with the exception of eNOS and phospho-eNOS Western
Blots, which were performed without dithiothreitol. After heating
at 90uC for 5 min, proteins were separated by SDS-PAGE and
transferred onto nitrocellulose membranes. Membranes were
blocked with 5% BSA and detection was carried out using specific
primary antibodies against: Adiponectin (Abcam, 1:2,000); eNOS
(Sigma, 1:3,000); phospho-eNOSSer1177 (Cell Signaling, C9C3
clone, 1:1,000); Akt (Calbiochem, 1:1,000), phospho-AktSer473
(Cell Signaling, 1:3,000); and c-actin (Sigma, 1:2,000). Chemilu-
minescent detection was performed using a secondary peroxidase-
linked anti-rabbit (Calbiochem, 1:10,000) or anti-sheep IgG
(Calbiochem, 1:13,000) and a detection system from Pierce KLP
(Rockford, IL, USA). The specificity of anti-NOS antibodies [54]
was determined by molecular mass comparisons. Signals were
quantified by densitometry using ImageQuantH (Amersham
Biosciences) and corrected using c-actin, except for serum
adiponectin determinations, which were normalized to AL.
IR and adiponectin immunoprecipitation
107 cells were plated over 75 cm2 and cultured with AL or CR
sera for 24 hours. Cells were homogenized in lysis buffer (50 mM
sodium phosphate, pH 7.4, 10% glycerol, 1% octyl phenol
ethoxylate, 10 mM sodium orthovanadate, 10 mM sodium
fluoride, 10 mM sodium pyrophosphate, supplemented with a
Sigma protease inhibitor cocktail). After 20 min over ice, tissues
lysates were centrifuged (13,000 g, 20 min, 4uC), and the resulting
supernatants were collected. Solubilized proteins (1 mg/mL) were
incubated overnight with 4 mg?mL21 anti-IR beta subunit
antibody at 4uC. Protein A-agarose (Sigma) beads (50%) were
added (80 mL?mL21), and the incubation was continued at 4uC for
2 hours. The beads were centrifuged (13,000 g, 1 min, 4uC),
washed five times in lysis buffer and suspended in Laemmli sample
buffer containing 5% 2-mercaptoethanol. Immunoprecipitation
specificity was verified through SDS-PAGE separation followed by
silver staining.
Adiponectin immunoprecipitation from the serum followed the
same steps described above, except the serum was not diluted. The
polyclonal adiponectin antibody was used at 50 mg?mL21. After a
12 hour incubation period, protein A-agarose beads (50%, Sigma)
were added (200 mL?mL21), and the incubation was continued at
4uC for 2 hours. The beads were centrifuged (13,000 g, 1 min,
4uC) and the serum was analyzed by Western Blot to confirm
efficiency.
Data analysis and statistics
Data shown are representative blots or averages 6 SEM of at
least three identical repetitions. Data were analyzed using
GraphPad Prism and compared using t-tests (for data pairs) or
two-tailed ANOVA followed by Tukey tests (multiple compari-
sons).
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